These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36211502)

  • 21. Coffee Silverskin Extract Protects against Accelerated Aging Caused by Oxidative Agents.
    Iriondo-DeHond A; Martorell P; Genovés S; Ramón D; Stamatakis K; Fresno M; Molina A; Del Castillo MD
    Molecules; 2016 Jun; 21(6):. PubMed ID: 27258247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coffee silverskin: characterization, possible uses, and safety aspects.
    Toschi TG; Cardenia V; Bonaga G; Mandrioli M; Rodriguez-Estrada MT
    J Agric Food Chem; 2014 Nov; 62(44):10836-44. PubMed ID: 25321090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value-Added Products from Coffee Waste: A Review.
    Lee YG; Cho EJ; Maskey S; Nguyen DT; Bae HJ
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of the Phytochemicals from Coffee and Cocoa By-Products with their Potential to Modulate Biomarkers of Metabolic Syndrome In Vitro.
    Rebollo-Hernanz M; Zhang Q; Aguilera Y; Martín-Cabrejas MA; Gonzalez de Mejia E
    Antioxidants (Basel); 2019 Aug; 8(8):. PubMed ID: 31387271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From Coffee Waste to Active Ingredient for Cosmetic Applications.
    Grigolon G; Nowak K; Poigny S; Hubert J; Kotland A; Waldschütz L; Wandrey F
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activating Effects of the Bioactive Compounds From Coffee By-Products on FGF21 Signaling Modulate Hepatic Mitochondrial Bioenergetics and Energy Metabolism
    Rebollo-Hernanz M; Aguilera Y; Martín-Cabrejas MA; Gonzalez de Mejia E
    Front Nutr; 2022; 9():866233. PubMed ID: 35392289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cosmeceutical activities of ethanol extract and its ethyl acetate fraction from coffee silverskin.
    Xuan SH; Lee KS; Jeong HJ; Park YM; Ha JH; Park SN
    Biomater Res; 2019; 23():2. PubMed ID: 30675376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing the effect of beauvericin on neuroblastoma SH-SY5Y cell line by natural products.
    Juan C; de Simone G; Sagratini G; Caprioli G; Mañes J; Juan-García A
    Toxicon; 2020 Dec; 188():164-171. PubMed ID: 33164869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel antioxidant beverage for body weight control based on coffee silverskin.
    Martinez-Saez N; Ullate M; Martin-Cabrejas MA; Martorell P; Genovés S; Ramon D; del Castillo MD
    Food Chem; 2014 May; 150():227-34. PubMed ID: 24360444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological Changes and Component Characterization of Coffee Silverskin.
    Wang X; Hong DF; Hu GL; Li ZR; Peng XR; Shi QQ; Qiu MH
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coffee silverskin extracts: Quantification of 30 bioactive compounds by a new HPLC-MS/MS method and evaluation of their antioxidant and antibacterial activities.
    Nzekoue FK; Angeloni S; Navarini L; Angeloni C; Freschi M; Hrelia S; Vitali LA; Sagratini G; Vittori S; Caprioli G
    Food Res Int; 2020 Jul; 133():109128. PubMed ID: 32466943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Use of a Coffee Industry By-Product in a Cereal-Based Extruded Food Product.
    Beltrán-Medina EA; Guatemala-Morales GM; Padilla-Camberos E; Corona-González RI; Mondragón-Cortez PM; Arriola-Guevara E
    Foods; 2020 Jul; 9(8):. PubMed ID: 32727015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Potential of Spent Coffee Grounds in Functional Food Development.
    Bevilacqua E; Cruzat V; Singh I; Rose'Meyer RB; Panchal SK; Brown L
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coffee By-Products and Their Suitability for Developing Active Food Packaging Materials.
    Oliveira G; Passos CP; Ferreira P; Coimbra MA; Gonçalves I
    Foods; 2021 Mar; 10(3):. PubMed ID: 33806924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UHPLC-PDA-ESI-TOF/MS metabolic profiling and antioxidant capacity of arabica and robusta coffee silverskin: Antioxidants vs phytotoxins.
    Panusa A; Petrucci R; Lavecchia R; Zuorro A
    Food Res Int; 2017 Sep; 99(Pt 1):155-165. PubMed ID: 28784472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scientometric Overview of Coffee By-Products and Their Applications.
    Durán-Aranguren DD; Robledo S; Gomez-Restrepo E; Arboleda Valencia JW; Tarazona NA
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation of Nano/Micro-Carriers Loaded with an Enriched Extract of Coffee Silverskin: Physicochemical Properties, In Vitro Release Mechanism and In Silico Molecular Modeling.
    Fathi F; Ebrahimi SN; Prior JAV; Machado SML; Kouchaksaraee RM; Oliveira MBPP; Alves RC
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Converting environmental risks to benefits by using spent coffee grounds (SCG) as a valuable resource.
    Stylianou M; Agapiou A; Omirou M; Vyrides I; Ioannides IM; Maratheftis G; Fasoula D
    Environ Sci Pollut Res Int; 2018 Dec; 25(36):35776-35790. PubMed ID: 29860699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Healthy and Harmful Maillard Reaction Products in a Novel Coffee Cascara Beverage: Melanoidins and Acrylamide.
    Iriondo-DeHond A; Elizondo AS; Iriondo-DeHond M; Ríos MB; Mufari R; Mendiola JA; Ibañez E; Castillo MDD
    Foods; 2020 May; 9(5):. PubMed ID: 32408584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pocket-4-Life project, bioavailability and beneficial properties of the bioactive compounds of espresso coffee and cocoa-based confectionery containing coffee: study protocol for a randomized cross-over trial.
    Mena P; Tassotti M; Martini D; Rosi A; Brighenti F; Del Rio D
    Trials; 2017 Nov; 18(1):527. PubMed ID: 29121975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.